These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 20001868)

  • 1. Dienogest: a new therapeutic agent for the treatment of endometriosis.
    Harada T; Taniguchi F
    Womens Health (Lond); 2010 Jan; 6(1):27-35. PubMed ID: 20001868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, double-blind, multicenter, controlled trial.
    Harada T; Momoeda M; Taketani Y; Aso T; Fukunaga M; Hagino H; Terakawa N
    Fertil Steril; 2009 Mar; 91(3):675-81. PubMed ID: 18653184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.
    Grandi G; Xholli A; Napolitano A; Palma F; Cagnacci A
    Reprod Sci; 2015 May; 22(5):626-32. PubMed ID: 25394646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dienogest mediates midkine suppression in endometriosis.
    Nirgianakis K; Grandi G; McKinnon B; Bersinger N; Cagnacci A; Mueller M
    Hum Reprod; 2016 Sep; 31(9):1981-6. PubMed ID: 27412246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment.
    Morotti M; Sozzi F; Remorgida V; Venturini PL; Ferrero S
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():188-92. PubMed ID: 25461377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, placebo-controlled, double-blind, comparative study of dienogest at 1 mg/day in patients with primary and secondary dysmenorrhea.
    Osuga Y; Hayashi K; Kanda S
    Fertil Steril; 2020 Mar; 113(3):627-635.e1. PubMed ID: 32192595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dienogest, a synthetic progestin, down-regulates expression of CYP19A1 and inflammatory and neuroangiogenesis factors through progesterone receptor isoforms A and B in endometriotic cells.
    Ichioka M; Mita S; Shimizu Y; Imada K; Kiyono T; Bono Y; Kyo S
    J Steroid Biochem Mol Biol; 2015 Mar; 147():103-10. PubMed ID: 25533385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the efficacy, safety, and clinically recommended dose of dienogest in the treatment of primary dysmenorrhea: a randomized, double-blind, multicenter, placebo-controlled study.
    Osuga Y; Hayashi K; Kanda S
    Fertil Steril; 2020 Jan; 113(1):167-175. PubMed ID: 31727415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dienogest in the treatment of endometriosis.
    Bizzarri N; Remorgida V; Leone Roberti Maggiore U; Scala C; Tafi E; Ghirardi V; Salvatore S; Candiani M; Venturini PL; Ferrero S
    Expert Opin Pharmacother; 2014 Sep; 15(13):1889-902. PubMed ID: 25069386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Dienogest for Treatment of Recurrent Endometriosis: Multicenter Data.
    Lee JH; Song JY; Yi KW; Lee SR; Lee DY; Shin JH; Cho S; Seo SK; Kim SH
    Reprod Sci; 2018 Oct; 25(10):1515-1522. PubMed ID: 29848190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis.
    Strowitzki T; Marr J; Gerlinger C; Faustmann T; Seitz C
    Int J Gynaecol Obstet; 2012 Jun; 117(3):228-33. PubMed ID: 22459918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacology of dienogest.
    Ruan X; Seeger H; Mueck AO
    Maturitas; 2012 Apr; 71(4):337-44. PubMed ID: 22364708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dienogest was effective in treating hemorrhagic ascites caused by endometriosis: a case report.
    Asano R; Nakazawa T; Hirahara F; Sakakibara H
    J Minim Invasive Gynecol; 2014; 21(6):1110-2. PubMed ID: 24780384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of dienogest effects upon 3,3'-diindolylmethane supplementation in models of endometriosis and clinical cases.
    Morales-Prieto DM; Herrmann J; Osterwald H; Kochhar PS; Schleussner E; Markert UR; Oettel M
    Reprod Biol; 2018 Sep; 18(3):252-258. PubMed ID: 30001982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for non-response and discontinuation of Dienogest in endometriosis patients: A cohort study.
    Nirgianakis K; Vaineau C; Agliati L; McKinnon B; Gasparri ML; Mueller MD
    Acta Obstet Gynecol Scand; 2021 Jan; 100(1):30-40. PubMed ID: 32767677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New treatment strategy for endometriosis using progestin-primed ovarian stimulation with dienogest: A prospective cohort study, comparison of dienogest versus dydrogesterone.
    Iwami N; Kawamata M; Ozawa N; Yamamoto T; Watanabe E; Mizuuchi M; Moriwaka O; Kamiya H
    Reprod Biol; 2021 Mar; 21(1):100470. PubMed ID: 33333410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Effectiveness of Dienogest (Visanne®) for Treatment of Endometriosis: A Large Prospective Cohort Study.
    Cho B; Roh JW; Park J; Jeong K; Kim TH; Kim YS; Kwon YS; Cho CH; Park SH; Kim SH
    Reprod Sci; 2020 Mar; 27(3):905-915. PubMed ID: 32052358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dienogest improves human leucocyte antigen-DR underexpression and reduces tumour necrosis factor-α production in peritoneal fluid cells from women with endometriosis.
    Maeda N; Izumiya C; Taniguchi K; Matsushima S; Mita S; Shimizu Y; Fukaya T
    Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():48-51. PubMed ID: 24793935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy and safety of combined estradiol valerate and dienogest: a new no-bleed treatment.
    von Schoultz B
    Climacteric; 2003 Aug; 6 Suppl 2():24-32. PubMed ID: 14669841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain.
    Kitawaki J; Kusuki I; Yamanaka K; Suganuma I
    Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):212-6. PubMed ID: 21474232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.